Review in Biomolecules, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 49% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
1 citing paper in PubMed, 3 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
2 authors at 2 institutions in 1 country.
Mark E DumontDepartment of Biochemistry and Biophysics, University of Rochester Medical Center, Rochester, NY 14642, USA.ORCID 0000-0002-9078-523X
James B KonopkaDepartment of Microbiology and Immunology, Stony Brook University, Stony Brook, NY 11794-5222, USA.ORCID 0000-0001-5989-4086
Stony Brook University · USUniversity of Rochester Medical Center · US
Funding
TOOLS FOR HIGH THROUGHPUT STRUCTURAL BIOLOGYU54GM074899 · NIGMS · HAUPTMAN-WOODWARD MEDICAL RESEARCH INST · PI DETITTA, GEORGE T · 2005 to 2010
$16.5M
Regulation of Morphogenesis in C. albicansR01AI047837 · NIAID · STATE UNIVERSITY NEW YORK STONY BROOK · PI James B Konopka · 2001 to 2026
$8.8M
Multi-Level Optimization of Membrane Proteins for CrystallographyU54GM094611 · NIGMS · HAUPTMAN-WOODWARD MEDICAL RESEARCH INST · PI DUMONT, MARK E. · 2010 to 2014
$6.3M
Signal pathways controlling the bud to hypha transitionR01GM116048 · NIGMS · STATE UNIVERSITY NEW YORK STONY BROOK · PI KONOPKA, JAMES B · 2015 to 2022
$2.5M
G PROTEIN COUPLED RECEPTOR ACTIVATION STUDIED IN YEASTR01GM059357 · NIGMS · UNIVERSITY OF ROCHESTER · PI DUMONT, MARK E. · 1999 to 2009
$2.2M
Genetic Optimization of Membrane Protein Production for CrystallizationR01GM084083 · NIGMS · UNIVERSITY OF ROCHESTER · PI DUMONT, MARK E. · 2009 to 2012
$1.3M
Mechanisms of G Protein Coupled Receptor Signaling in the Yeast Pheromone PathwayR01GM114974 · NIGMS · UNIVERSITY OF ROCHESTER · PI DUMONT, MARK E. · 2015 to 2018
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Comparison of Experimental Approaches Used to Determine the Structure and Function of the Class D G Protein-Coupled Yeast α-Factor Receptor. · full record | OpenQuestion